The Asia-Pacific prefilled syringes market, valued at USD 783 million in 2025, is projected to reach USD 858 million in 2026 and USD 1,606 million by 2035, representing a CAGR of 7.2% during the forecast period 2026 to 2035. Demand has expanded from hospital-based dose preparation toward ready-to-use formats that support biologics, vaccination and self-administration. Prefilled presentation reduces preparation steps, dosing errors, contamination exposure and drug waste relative to conventional v...

The global at home blood collection devices market, valued at USD 857 million in 2025, is projected to reach USD 941 million in 2026 and USD 2,767 million by 2035, with a CAGR of 12.7% during the forecast period 2026 to 2035. The market is gaining momentum as healthcare systems increasingly adopt decentralized diagnostics, home-care and remote patient monitoring. At home collection can improve patient convenience by reducing travel, clinic visits and dependence on trained personnel, making the a...

The global prenatal diagnostic software market is estimated at USD 290.1 million in 2026 and is projected to reach USD 779.6 million by 2035, expanding at a CAGR of 11.6% during 2026-2035. Growth is being supported by broader prenatal screening, increasing use of software-assisted fetal imaging, and greater integration of risk assessment, reporting and clinical workflow tools.

The global wearable injectors market, valued at USD 6.5 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 13.0 billion by 2035, representing a CAGR of 7.4% during the forecast period 2026 to 2035. The total market combines two clinically and commercially distinct segments: wearable injectors used for insulin delivery and wearable injectors used for non-insulin drugs. The insulin segment is centered on diabetes management and continuous or automated insulin delivery, while th...

The global Injectable PrEP Market is expected to rise from USD 1.62 billion in 2026 and is projected to reach USD 7.15 billion by 2040, growing at a CAGR of 11.2% over the forecast period 2026 to 2040, driven by six-month dosing, reimbursement expansion, and generic access. Based on care setting, hospitals and specialist clinics capture 74.0% market share in 2026, whereas retail and community pharmacies register a 23.8% CAGR through 2040, supported by decentralized delivery. Based on funding and...

The Asia-Pacific medical device contract manufacturing market, valued at USD 17.3 billion in 2025, is projected to reach USD 18.9 billion in 2026 and USD 38.1 billion by 2035, with a CAGR of 8.1% during the forecast period from 2026 to 2035. The region includes a growing network of contract manufacturers serving complex medical device categories, including minimally invasive devices, diagnostic equipment, cardiovascular products, orthopedic implants, diabetes care solutions, wearable medical dev...

The global insulin pump market, valued at USD 6.1 billion in 2025, is projected to reach USD 6.5 billion in 2026 and USD 13.6 billion by 2035, representing a CAGR of 8.5% during the forecast period 2026 to 2035. In terms of type of pump, the patch pumps segment holds the highest (more than 60%) share of the current market. The emergence of automated insulin delivery systems represents a defining shift in the domain. These platforms use real-time glucose data and algorithms to adjust insulin deli...

The global exoskeleton market, valued at USD 2.9 billion in 2025, is projected to reach USD 3.7 billion in 2026 and USD 20.3 billion by 2035, representing a CAGR of 20.8% during the forecast period 2026 to 2035. The exoskeleton market is gaining relevance as mobility impairment becomes a larger clinical, social, and economic burden. Neurological conditions are now among the leading causes of disability worldwide; in 2025, the World Health Organization reported that neurological conditions affect...

The North America medical device contract manufacturing market, valued at USD 40.9 billion in 2025, is projected to reach USD 43.9 billion in 2026 and USD 75.5 billion by 2035, with a CAGR of 6.2% during the forecast period 2026 to 2035. North America represents the largest and most advanced market for medical device contract manufacturing, driven by its robust medtech ecosystem and strong culture of innovation. The US, in particular, continues to generate significant demand for contract manufac...

The global large volume wearable injectors market, valued at USD 12.6 billion in 2025, is projected to reach USD 16.4 billion in 2026 and USD 31.4 billion by 2035, representing a CAGR of 7.5% during the forecast period 2026 to 2035. The market numbers have been calculated by taking into account the revenues generated through sales of large volume wearable injectors and related drug-device combination products. Based on market share distribution by therapeutic area, devices used to treat autoimmu...

The global surgical robots market, valued at USD 9.8 billion in 2025, is projected to reach USD 10.6 billion in 2026 and USD 22.9 billion by 2035, with a 8.9% CAGR during the forecast period 2026 to 2035. In terms of geography, North America captures the majority of the market share.

The global next generation contact lenses and visual prostheses market, valued at USD 0.36 billion in 2024, is projected to reach USD 0.60 billion in 2025 and USD 16.97 billion by 2035, representing a CAGR of 39.7% during the forecast period. It is worth highlighting here that there is a rapid increase witnessed in the number of blind and partially sighted individuals. According to the National Eye Institute, nearly 1.3 million people are blind, while 2.9 million individuals have poor vision, in...

The global battery-free implants market is expected to rise from USD 9.3 billion in 2026 to reach USD 83.4 billion by 2040, growing at a CAGR of 17.0% over the forecast period 2026 to 2040, driven by wireless power transfer, miniaturization, and fewer replacement surgeries. Battery-free implant development is shifting from isolated passive sensors toward programmable therapeutic and diagnostic platforms. Near-field inductive coupling still holds 32.0% of 2026 revenue because mature coils support...

The ultrasound market is estimated to grow from USD 9.6 billion in 2025 to reach USD 10.2 billion in 2026 and USD 16.0 billion by 2035, representing a CAGR of 5.1% during the forecast period. In May 2026, ClearPoint Neuro entered into a collaboration with Sungkyunkwan University to expand its drug delivery ecosystem. The collaboration follows successful preclinical trials demonstrating ultrasound-enabled delivery across the blood-brain barrier, aiming to accelerate commercialization and global e...

The global sexually transmitted disease (STD) testing market is expected to rise from USD 12.3 billion in 2026 to reach USD 33.0 billion by 2040, growing at a CAGR of 7.3% over the forecast period 2026 to 2040, driven by wider screening access and molecular-test adoption. Based on geography, North America captures 42.0% market share in 2026, whereas Asia-Pacific registers a 9.4% CAGR through 2040, supported by expanding screening infrastructure.

The global pulsed field ablation market, valued at USD 2.3 billion in 2025, is projected to reach USD 3.2 billion in 2026 and USD 14.6 billion by 2035, representing a CAGR of 18.4% during the forecast period 2026 to 2035. Clinical and preclinical research continues to expand the PFA evidence base, with multiple energy-delivery systems and procedural workflows under investigation. For instance, Boston Scientific’s FARAPULSE™ pulsed-field ablation (PFA) system demonstrated symptomatic relief i...

The global prefilled syringes market, valued at USD 3,818 million in 2025, is projected to reach USD 4,122 million in 2026 and USD 6,750 million by 2035, representing a CAGR of 5.6% during the forecast period 2026 to 2035. In terms of therapeutic area, the market for hematological disorders is likely to capture the highest share (more than 65%) of the global prefilled syringes industry in 2026 due to the high volume of anticoagulants and blood stimulants standardized for delivery via prefilled f...

The global drug reconstitution systems market, valued at USD 5.4 billion in 2025, is projected to reach USD 5.9 billion in 2026 and USD 10.8 billion by 2035, representing a CAGR of 7.0% during the forecast period 2026 to 2035. In terms of type of reconstitution system, cartridges hold the highest share (close to 50%) of the current market. Based on fabrication material, the glass segment holds the largest share of the current market.

The global implantable biosensors market is expected to rise from USD 2.90 billion in 2026 to reach USD 9.26 billion by 2040, growing at a CAGR of 8.6% over the forecast period 2026 to 2040, driven by long-duration continuous monitoring. Based on sensor type, electrophysiological sensors capture 37.0% market share in 2026, whereas electrochemical biosensors register a 9.9% CAGR through 2040, supported by longer-life metabolite sensing.

The global medication adherence market, valued at USD 5.45 billion in 2025, is projected to reach USD 6.08 billion in 2026 and USD 15.35 billion by 2035, representing a CAGR of 10.92% during the forecast period 2026 to 2035. In May 2026, Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, announced its participation at the BofA Securities 2026 Healthcare Conference. In January 2026, MIT engineers developed ingestible pills equipped with biod...